• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
40 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

JNJ

Johnson & Johnson
US$146.82-1.5%-10.3%US$352.2bUS$173.60PE18.5xE5.1%3.4%

UTHR

United Therapeutics
US$238.261.8%2.6%US$11.0bUS$288.02PE11.4xE7.5%n/a

600566

Hubei Jumpcan Pharmaceutical
CN¥40.20-4.9%27.4%CN¥37.1bCN¥52.36PE12.4xE8.5%3.2%

2773

Chengdu Kanghong Pharmaceutical Group
CN¥21.0018.8%13.5%CN¥19.3bn/aPE17xE14.7%1.8%

300009

Anhui Anke Biotechnology (Group)
CN¥9.971.0%-9.8%CN¥16.7bCN¥19.54PE19xE16.7%2.5%

301207

Hualan Biological Vaccine
CN¥22.02-4.6%-32.6%CN¥13.2bCN¥33.20PE16.4xE24.2%2.7%

H02

Haw Par
S$9.860.1%2.5%S$2.2bn/aPE10.1xn/a4.1%

6600

SciClone Pharmaceuticals (Holdings)
HK$18.000.1%51.8%HK$11.0bHK$17.86PE9xE4.7%0%

600976

Jianmin Pharmaceutical GroupLtd
CN¥56.354.1%-15.1%CN¥8.6bCN¥87.74PE16.4xE20.7%2.1%

300119

Tianjin Ringpu Bio-TechnologyLtd
CN¥15.73-1.4%-26.8%CN¥7.3bCN¥21.34PE15.8xE17.7%2.5%

603367

Cisen Pharmaceutical
CN¥15.843.9%-1.7%CN¥7.2bn/aPE13.6xn/a2.8%

2877

China Shineway Pharmaceutical Group
HK$9.211.2%12.7%HK$7.0bHK$14.09PE6.6xE14.5%6.3%

4559

Zeria Pharmaceutical
JP¥2,059.000.05%-16.0%JP¥90.8bJP¥2,810.00PE10.5xE3.0%2.1%

603676

Tibet Weixinkang Medicine
CN¥9.3117.0%-37.5%CN¥4.1bn/aPE16.3xn/a2.5%

A003090

Daewoong
₩18,700.003.1%25.3%₩764.7b₩25,000.00PE5xS7.0%0.5%

SFA

Sopharma AD
лв6.00-1.0%8.3%лв993.7mлв7.14PE10.4xn/a15.0%

300439

Medicalsystem Biotechnology
CN¥9.8811.0%-17.7%CN¥3.8bn/aPE14.4xn/a1.4%

DEVA

Deva Holding
₺73.35-0.7%88.1%₺14.7bn/aPE6.4xn/a0.2%

4886

ASKA Pharmaceutical HoldingsLtd
JP¥2,260.001.7%73.8%JP¥64.0bJP¥2,666.67PE9.8xE-0.5%1.8%

2412

Hunan Hansen Pharmaceutical
CN¥5.7510.2%-13.4%CN¥2.9bn/aPE13.9xn/a5.2%

A000020

Dongwha Pharm.Co.Ltd
₩8,750.000.6%4.4%₩242.5bn/aPE8.8xn/a2.1%

1061

Essex Bio-Technology
HK$2.24-3.4%-38.6%HK$1.3bn/aPE4.6xn/a4.0%

A016580

Whan In PharmLtd
₩13,860.000.5%-14.3%₩211.6b₩21,000.00PE7.1xE1.1%2.2%

2633

Jacobson Pharma
HK$0.56-1.8%-41.1%HK$1.1bn/aPE4.6xn/a8.7%
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.